US Patent 7084245 Peptides that bind to the erythropoietin receptor
Patent 7084245 was granted and assigned to Affymax, Inc. on August, 2006 by the United States Patent and Trademark Office.
All edits
Edits on 16 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 29 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 4 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 25 Nov, 2023
Golden AI
Edits made to:
Infobox (+15 properties)
Article (+393 characters)
Article
Patent abstract
The present invention relates to peptide compounds that are agonists of the erythropoietin receptor (EPO-R). The invention also relates to therapeutic methods using such peptide compounds to treat disorders associated with insufficient or defective red blood cell production. Pharmaceutical compositions, which comprise the peptide compounds of the invention, are also provided.
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Balu Palani0
Christopher P. Holmes0
David Tumelty0
Genet Zemede0
Guy Lalonde0
Peter J. Schatz0
Qun Yin0
Date of Patent
August 1, 2006
0Patent Application Number
108449680
Date Filed
May 12, 2004
0Patent Primary Examiner
Golden AI
Edits made to:
US Patent 7084245 Peptides that bind to the erythropoietin receptor
Find more entities like US Patent 7084245 Peptides that bind to the erythropoietin receptor
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.